Summit Therapeutics, Intel among Monday’s market cap stock movers
Monday’s market has seen notable fluctuations across a range of stocks, with significant movements observed in both the mega-cap and large-cap categories. Summit Therapeutics PLC (NASDAQ: SMMT ) and Intel Corp (NASDAQ: INTC ) experienced upward trends, while Maplebear (CART) faced a downturn. These intra-day stock movements are a reflection of the dynamic nature of the financial markets. Below are highlights of some of the biggest stock movers, from mega-caps to small caps.
Mega-Cap Movers:
- None listed today.
Large-Cap Stock Movers:
- Summit Therapeutics PLC (SMMT): +8.18%
- Reinvent Technology Partners Y (AUR): +8.57%
- Intel Corp (INTC): +3.82%
- Biontech Se (NASDAQ: BNTX ): +4.02%
- Maplebear (CART): -3.63%
- Li Auto Inc (NASDAQ: LI ): +3.62%
- BeiGene (NASDAQ: ONC ): +3.09%
- Teva Pharmaceutical Inds Ltd (NYSE: TEVA ): +2.82%
- Carnival Corp-Exch (NYSE: CCL ); Yieldstreet and Upgrade Partner to Expand Access to Consumer Credit Investing: +2.93%
Mid-Cap Stock Movers:
- SS Innovations International (SSII): +41.88%
- Pony Ai Inc (PONY): +23.11%
- VEON Ltd (AS: VON ) (VEON (NASDAQ: VEON )): +13.45%
- ADMA Biologics Inc (NASDAQ: ADMA ): +14.89%
- Wildhorse Resource Development Corp (WRD): -11.39%
- Biohaven Pharmaceutical Holding Co (NYSE: BHVN ); Biohaven secures up to $600 million from Oberland Capital: +8.22%
- NIO Inc (NYSE: NIO ): +6.2%
- Revolution Medicines Inc (NASDAQ: RVMD ); Revolution Medicines Presents Initial Data from Zoldonrasib (RMC-9805) Study at the 2025 AACR Annual Meeting: +6.4%
- Lufax Holding Ltd (NYSE: LU ): -4.65%
Small-Cap Stock Movers:
- Plug Power (NASDAQ: PLUG ); Plug Power secures $525 million debt facility, eyes growth: +41.7%
- CG Oncology (CGON): +30.08%
- Sabre Corpo (NASDAQ: SABR ); Sabre sells hospitality unit to TPG for $1.1 billion: +20.09%
- Cree Inc. (NYSE: WOLF ): +25.54%
For real-time, market-moving news, join Investing Pro.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.